新興市場美元債-iShares EMB 深 滬
已收盤 10-03 16:00:00 美东时间
95.21
+0.040
+0.04%
華盛通- 最 高95.33
- 今 開95.27
- 成交量 460.08万股
- 最 低 95.13
- 昨 收 95.17
- 總市值 137.10亿
- 52周最高 95.5075
- 市盈率 靜 --
- 換手率 3.20%
- 52周最低 82.3869
- 委 比 -44.03%
- 總股本 1.44亿
- 歷史最高 95.5075
- 量 比 0.68
- 振 幅 0.21%
- 歷史最低 51.8899
- 每 手 1
- 風險率 2.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Embelton Limited Updates Director’s Shareholding
The latest update is out from Embelton Limited ( ($AU:EMB) ). Embelton Limited ...
10-02 11:27
Globant unveils new $125 million share repurchase program
LUXEMBOURG, Oct. 1, 2025 /PRNewswire/ -- Yesterday, the board of directors of Globant S.A. (NYSE: GLOB) approved a new share repurchase program, authorizing the allocation of up to $50 milli...
10-02 04:25
FDA Approves Eli Lilly's Drug For Advanced Breast Cancer
Eli Lilly secured FDA approval for breast cancer drug Inluriyo and EU clearance for Alzheimer's therapy Kisunla following strong Phase 3 data.
09-26 21:12
Eli Lilly wins approval of imlunestrant for breast cancer
The U.S. FDA has approved Eli Lilly's (NYSE:LLY) imlunestrant, under the brand name Inluriyo, as a second-line therapy for ER+, HER2–, and ESR1-mutated advanced or metastatic breast cancer. The oral ...
09-26 03:21
U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor In the Phase 3 EMBER-3 trial, Inluriyo ...
09-26 02:01
Pembroke VCT PLC Secures Shareholder Approval at AGM
An update from Pembroke VCT ( ($GB:PEMB) ) is now available. Pembroke VCT PLC a...
09-26 00:47
万向钱潮：万向一二三已完成半固态电池安全突破
9月25日，万向钱潮（000559.SZ）在发布的投资者关系活动记录表中称，公司已将机器人业务确立为继轴承与汽车底盘系统之后的第三大战略业务板块，系统推进人形机...
09-25 16:38
Embelton Limited Releases Annual Report Highlighting Strategic Growth
The latest announcement is out from Embelton Limited ( ($AU:EMB) ). Embelton Li...
09-22 10:38
Flywire Corporation (FLYW) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Sept. 19, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Flywire Corporation ("Flywire" or the "Company") (NASDAQ: FLYW) h...
09-20 03:51
Pembroke VCT Reduces Share Capital Through Buyback
The latest announcement is out from Pembroke VCT ( ($GB:PEMB) ). Pembroke VCT p...
09-20 00:22
公司簡介
公司名稱
|
iShares JP Morgan USD Emerging Markets Bond ETF
|
行業分類
|
Investment Trusts/Mutual Funds
|
業務描述
|
Exists as exchange Traded Fund
|
Embelton Limited Updates Director’s Shareholding
The latest update is out from Embelton Limited ( ($AU:EMB) ). Embelton Limited ...
10-02 11:27
Globant unveils new $125 million share repurchase program
LUXEMBOURG, Oct. 1, 2025 /PRNewswire/ -- Yesterday, the board of directors of Globant S.A. (NYSE: GLOB) approved a new share repurchase program, authorizing the allocation of up to $50 milli...
10-02 04:25
FDA Approves Eli Lilly's Drug For Advanced Breast Cancer
Eli Lilly secured FDA approval for breast cancer drug Inluriyo and EU clearance for Alzheimer's therapy Kisunla following strong Phase 3 data.
09-26 21:12
Eli Lilly wins approval of imlunestrant for breast cancer
The U.S. FDA has approved Eli Lilly's (NYSE:LLY) imlunestrant, under the brand name Inluriyo, as a second-line therapy for ER+, HER2–, and ESR1-mutated advanced or metastatic breast cancer. The oral ...
09-26 03:21
U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor In the Phase 3 EMBER-3 trial, Inluriyo ...
09-26 02:01
Pembroke VCT PLC Secures Shareholder Approval at AGM
An update from Pembroke VCT ( ($GB:PEMB) ) is now available. Pembroke VCT PLC a...
09-26 00:47
万向钱潮：万向一二三已完成半固态电池安全突破
9月25日，万向钱潮（000559.SZ）在发布的投资者关系活动记录表中称，公司已将机器人业务确立为继轴承与汽车底盘系统之后的第三大战略业务板块，系统推进人形机...
09-25 16:38
Embelton Limited Releases Annual Report Highlighting Strategic Growth
The latest announcement is out from Embelton Limited ( ($AU:EMB) ). Embelton Li...
09-22 10:38
Flywire Corporation (FLYW) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Sept. 19, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Flywire Corporation ("Flywire" or the "Company") (NASDAQ: FLYW) h...
09-20 03:51
Pembroke VCT Reduces Share Capital Through Buyback
The latest announcement is out from Pembroke VCT ( ($GB:PEMB) ). Pembroke VCT p...
09-20 00:22
年度
|
派息內容
| 派息日期 |
0.39
|
2025-10-06
| |
0.40
|
2025-09-05
| |
0.41
|
2025-08-06
| |
0.38
|
2025-07-07
| |
0.41
|
2025-06-05
| |
0.40
|
2025-05-06
| |
0.40
|
2025-04-04
| |
0.39
|
2025-03-06
| |
0.44
|
2025-02-06
| |
0.25
|
2025-01-03
| |
0.43
|
2024-12-23
| |
0.39
|
2024-12-05
| |
0.42
|
2024-11-06
| |
0.39
|
2024-10-04
| |
0.37
|
2024-09-06
| |
0.39
|
2024-08-06
| |
0.38
|
2024-07-05
| |
0.36
|
2024-06-07
| |
0.36
|
2024-05-07
| |
0.37
|
2024-04-05
| |
0.39
|
2024-03-07
| |
0.37
|
2024-02-07
| |
0.36
|
2023-12-20
| |
0.33
|
2023-12-07
| |
0.36
|
2023-11-07
| |
0.35
|
2023-10-06
| |
0.36
|
2023-09-08
| |
0.35
|
2023-08-07
| |
0.35
|
2023-07-10
| |
0.35
|
2023-06-07
| |
0.35
|
2023-05-05
| |
0.36
|
2023-04-07
| |
0.38
|
2023-03-07
| |
0.31
|
2023-02-07
| |
0.34
|
2022-12-21
| |
0.34
|
2022-12-07
| |
0.38
|
2022-11-07
| |
0.37
|
2022-10-07
| |
0.31
|
2022-09-08
| |
0.35
|
2022-08-05
| |
0.36
|
2022-07-08
| |
0.33
|
2022-06-07
| |
0.36
|
2022-05-06
| |
0.38
|
2022-04-07
| |
0.36
|
2022-03-07
| |
0.37
|
2022-02-07
| |
0.37
|
2021-12-22
| |
0.36
|
2021-12-07
| |
0.36
|
2021-11-05
| |
0.35
|
2021-10-07
| |
0.35
|
2021-09-08
| |
0.35
|
2021-08-06
| |
0.36
|
2021-07-08
| |
0.36
|
2021-06-07
| |
0.35
|
2021-05-07
| |
0.35
|
2021-04-08
| |
0.35
|
2021-03-05
| |
0.36
|
2021-02-05
| |
0.40
|
2020-12-23
| |
0.40
|
2020-12-07
| |
0.40
|
2020-11-06
| |
0.37
|
2020-10-07
| |
0.33
|
2020-09-08
| |
0.33
|
2020-08-07
| |
0.33
|
2020-07-08
| |
0.34
|
2020-06-05
| |
0.38
|
2020-05-07
| |
0.41
|
2020-04-07
| |
0.42
|
2020-03-06
| |
0.41
|
2020-02-07
| |
0.44
|
2019-12-26
| |
0.41
|
2019-12-06
| |
0.41
|
2019-11-07
| |
0.40
|
2019-10-07
| |
0.41
|
2019-09-09
| |
0.42
|
2019-08-07
| |
0.44
|
2019-07-08
| |
0.46
|
2019-06-07
| |
0.45
|
2019-05-07
| |
0.45
|
2019-04-05
| |
0.44
|
2019-03-07
| |
0.44
|
2019-02-07
| |
1.29
|
2018-12-24
| |
0.45
|
2018-12-07
| |
0.46
|
2018-11-07
| |
0.45
|
2018-10-05
| |
0.44
|
2018-09-10
| |
0.44
|
2018-08-07
| |
0.45
|
2018-07-09
| |
0.45
|
2018-06-07
| |
0.41
|
2018-05-07
| |
0.37
|
2018-04-06
| |
0.34
|
2018-03-07
| |
0.31
|
2018-02-07
| |
0.37
|
2017-12-28
| |
0.45
|
2017-12-07
| |
0.45
|
2017-11-07
| |
0.45
|
2017-10-06
| |
0.45
|
2017-09-08
| |
0.45
|
2017-08-07
| |
0.44
|
2017-07-10
| |
0.44
|
2017-06-07
| |
0.44
|
2017-05-05
| |
0.44
|
2017-04-07
| |
0.44
|
2017-03-07
| |
0.44
|
2017-02-07
| |
0.26
|
2016-12-29
| |
0.45
|
2016-12-07
| |
0.45
|
2016-11-07
| |
0.50
|
2016-10-07
| |
0.49
|
2016-09-08
| |
0.50
|
2016-08-05
| |
0.53
|
2016-07-08
| |
0.44
|
2016-06-07
| |
0.41
|
2016-05-06
| |
0.43
|
2016-04-07
| |
0.44
|
2016-03-07
| |
0.42
|
2016-02-05
| |
0.55
|
2015-12-31
| |
0.43
|
2015-12-07
| |
0.44
|
2015-11-06
| |
0.47
|
2015-10-07
| |
0.46
|
2015-09-08
| |
0.42
|
2015-08-07
| |
0.42
|
2015-07-08
| |
0.42
|
2015-06-05
| |
0.40
|
2015-05-07
| |
0.38
|
2015-04-08
| |
0.36
|
2015-03-06
| |
0.38
|
2015-02-06
| |
0.60
|
2014-12-31
| |
0.42
|
2014-12-05
| |
0.40
|
2014-11-07
| |
0.39
|
2014-10-07
| |
0.29
|
2014-09-08
| |
0.40
|
2014-08-07
| |
0.40
|
2014-07-08
| |
0.41
|
2014-06-06
| |
0.42
|
2014-05-07
| |
0.43
|
2014-04-07
| |
0.43
|
2014-03-07
| |
0.42
|
2014-02-07
| |
0.42
|
2014-01-02
| |
0.41
|
2013-12-06
| |
0.44
|
2013-11-07
| |
0.43
|
2013-10-07
| |
0.46
|
2013-09-09
| |
0.45
|
2013-08-07
| |
0.44
|
2013-07-08
| |
0.41
|
2013-06-07
| |
0.41
|
2013-05-07
| |
0.41
|
2013-04-05
| |
0.43
|
2013-03-07
| |
0.43
|
2013-02-07
| |
0.39
|
2013-01-02
| |
0.39
|
2012-12-07
| |
0.41
|
2012-11-07
| |
0.40
|
2012-10-05
| |
0.43
|
2012-09-10
| |
0.45
|
2012-08-07
| |
0.45
|
2012-07-09
| |
0.44
|
2012-06-07
| |
0.44
|
2012-05-07
| |
0.45
|
2012-04-09
| |
0.45
|
2012-03-07
| |
0.43
|
2012-02-07
| |
0.41
|
2012-01-04
| |
0.44
|
2011-12-07
| |
0.44
|
2011-11-07
| |
0.44
|
2011-10-07
| |
0.44
|
2011-09-08
| |
0.42
|
2011-08-05
| |
0.45
|
2011-07-08
| |
0.46
|
2011-06-07
| |
0.45
|
2011-05-06
| |
0.45
|
2011-04-07
| |
0.45
|
2011-03-07
| |
0.45
|
2011-02-07
| |
0.46
|
2011-01-04
| |
0.46
|
2010-12-07
| |
0.44
|
2010-11-05
| |
0.45
|
2010-10-07
| |
0.44
|
2010-09-08
| |
0.43
|
2010-08-06
| |
0.46
|
2010-07-08
| |
0.45
|
2010-06-07
| |
0.47
|
2010-05-07
| |
0.48
|
2010-04-08
| |
0.49
|
2010-03-05
| |
0.48
|
2010-02-05
| |
0.42
|
2010-01-05
| |
0.42
|
2009-12-07
| |
0.45
|
2009-11-06
| |
0.45
|
2009-10-07
| |
0.49
|
2009-09-08
| |
0.45
|
2009-08-07
| |
0.47
|
2009-07-08
| |
0.49
|
2009-06-05
| |
0.58
|
2009-05-07
| |
0.52
|
2009-04-07
| |
0.49
|
2009-03-06
| |
0.49
|
2009-02-06
| |
0.36
|
2009-01-02
| |
0.51
|
2008-12-05
| |
0.45
|
2008-11-07
| |
0.44
|
2008-10-07
| |
0.45
|
2008-09-08
| |
0.43
|
2008-08-07
| |
0.38
|
2008-07-08
| |
0.46
|
2008-06-06
| |
0.45
|
2008-05-07
| |
0.46
|
2008-04-07
| |
0.42
|
2008-03-07
| |
0.48
|
2008-02-07
| |
0.16
|
2007-12-27
|
